Expand CDXS Menu
CDXS MENU

CDXS Stock Summary and Trading Ideas (Codexis | NASDAQ:CDXS)

Charts for Today's Stock Price and Implied Volatility in Codexis

22-May-2026

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for CDXS by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Codexis (CDXS) Frequently Asked Questions

What does Codexis do?

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

What symbol and exchange does Codexis shares trade?

Codexis trades on the NASDAQ stock market under the symbol CDXS.

What is Codexis stock price doing today?

As of May 22, 2026, CDXS stock price declined to $2.49 with 838,009 million shares trading.

What is Codexis's Beta?

CDXS has a beta of 2.36, meaning it tends to be more sensitive to market movements. CDXS has a correlation of 0.13 to the broad based SPY ETF.

How much is Codexis worth?

CDXS has a market cap of $226.26 million. This is considered a Small Cap stock.

How much money does Codexis make?

Last quarter Codexis reported $15 million in Revenue and -$.10 earnings per share. This beat revenue expectation by $631,544 and exceeded earnings estimates by $.01.

What is the highest and lowest price Codexis traded in the last 3 year period?

In the last 3 years, CDXS traded as high as $6.08 and as low as $.96.

What are the top ETFs holding Codexis?

The top ETF exchange traded funds that CDXS belongs to (by Net Assets): VTI, IWM, VXF, IBB, IWO.

Is Codexis (CDXS) a good investment?

CDXS has underperformed the market in the last year with a price return of +1.2% while the SPY ETF gained +29.1%. However, in the short term, CDXS had mixed performance relative to the market. It has outperformed in the last 3 months, returning +112.8% vs +8.4% return in SPY. But in the last 2 weeks, CDXS shares have been beat by the market, returning -12.6% compared to an SPY return of +1.1%.

What are the support and resistance levels for Codexis (CDXS)?

CDXS support price is $2.39 and resistance is $2.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CDXS shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes